Emerald Biostructures announced this week the formation of its scientific advisory board to which it appointed John Hunt, John McCall, John Mulligan, and Lynn Silver.
Hunt is an associate professor at Columbia University and the co-director of the crystallography group Northeast Structural Genomics. McCall is the president of PharMac and was previously vice president of research at Pfizer and global head of chemistry at Pharmacia and Pharmacia & Upjohn. Mulligan is the founder and former CEO of Blue Heron Biotechnology, which was acquired in August by OriGene. Silver currently works as a consultant in preclinical development and antibacterial discovery for the pharmaceutical industry. Previously, she was a researcher at Merck.